Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| WESTELL TECH | WSTL | 5.69% |
| STEIN MART I | SMRT | 2.56% |
| ALLIANCE FIB | AFOP | 2.47% |
| MAXWELL TECH | MXWL | 2.42% |
| SYNAPTICS IN | SYNA | 2.23% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
NextGen Healthcare Information Systems, a full subsidiary of Quality Systems ( QSII - Analyst Report ) , recently revealed that it has partnered with Microsoft Corporation (MSFT) to create and commercialize the NextGen MedicineCabinet application. This is the first client-focused portable healthcare IT offering intended for the Windows 8 set up, from Microsoft and NextGen Healthcare partnership. With the NextGen MedicineCabinet application, clients can develop, maintain, monitor and compare their medical records.
The NextGen MedicineCabinet application is free. It may be acquired at the Microsoft app store. Customers can add a drug to their list along with the dosage and then run the application. The customer receives notices for each dose and can indicate his/her response. Medical records aid patients and doctors can thereby avoid accidental irregularities in care.
Quality Systems runs a pure-play business model in an attractive industry with a large number of catalysts, which provoke frequent speculation about mergers and acquisitions. On the positive side, we observe the high proportion of recurring revenues. Of late, however, growth of its pipeline metric has seen a falling trend along with progressively fewer signed deals on a quarterly basis.
The company has made multiple acquisitions to bolster organic growth. Its acquisitions are expected to facilitate its entry in the small hospital segment. We are concerned about execution risk emanating from Quality Systems’ entry into the rural inpatient market.
Moreover, competition is intense from well regarded players such as Athenahealth ( ATHN - Analyst Report ) , Allscripts Healthcare Solutions ( MDRX - Analyst Report ) , Cerner Corporation ( CERN - Analyst Report ) and others. Price discounting is frequent, particularly at the lower end, and Software as a Service (SaaS) based model appears to have exacerbated pricing pressure.
Quality Systems has traditionally focused on providing solutions for physician practices. However, core ambulatory EHR providers such as Quality Systems will see opportunities for product sales shrink, as physician groups are increasingly absorbed into hospitals.
We have a long-term Neutral recommendation on the stock which carries a short-term Zacks #3 Rank (Hold).
Read the full reports :
Analyst Report on CERN
Analyst Report on ATHN
Analyst Report on MDRX
Analyst Report on QSII